These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21476889)

  • 21. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
    Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
    J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insular thyroid carcinoma: a retrospective clinicopathologic study.
    Hod R; Bachar G; Sternov Y; Shvero J
    Am J Otolaryngol; 2013; 34(4):292-5. PubMed ID: 23357591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deaths due to differentiated thyroid cancer: a South Island, New Zealand experience: 1984-2009.
    Brownlie BJ; Turner J; Abdelaal AS
    N Z Med J; 2012 Oct; 125(1363):13-21. PubMed ID: 23159897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage II differentiated thyroid cancer: A mixed bag.
    Pathak KA; Klonisch TC; Nason RW
    J Surg Oncol; 2016 Jan; 113(1):94-7. PubMed ID: 26628095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cause of death in patients with well-differentiated thyroid carcinoma.
    Beasley NJ; Walfish PG; Witterick I; Freeman JL
    Laryngoscope; 2001 Jun; 111(6):989-91. PubMed ID: 11404609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
    Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
    Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of site of recurrence in patients with recurrent well-differentiated thyroid cancer.
    Waseem Z; Palme CE; Walfish P; Freeman JL
    J Otolaryngol; 2004 Dec; 33(6):339-44. PubMed ID: 15971647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood and adolescent thyroid carcinoma.
    Grigsby PW; Gal-or A; Michalski JM; Doherty GM
    Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
    Mihailovic J; Nikoletic K; Srbovan D
    J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
    Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
    Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review.
    Hung W; Sarlis NJ
    Thyroid; 2002 Aug; 12(8):683-702. PubMed ID: 12225637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history, treatment, and course of papillary thyroid carcinoma.
    DeGroot LJ; Kaplan EL; McCormick M; Straus FH
    J Clin Endocrinol Metab; 1990 Aug; 71(2):414-24. PubMed ID: 2380337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing incidence and characteristics of differentiated thyroid cancer in Huntington, West Virginia.
    Merhy J; Driscoll HK; Leidy JW; Chertow BS
    Thyroid; 2001 Nov; 11(11):1063-9. PubMed ID: 11762717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The surgical treatment and prognostic factors of well-differentiated thyroid cancers in Chinese patients: a 20-year experience.
    Tseng LM; Lee CH; Wang HC; Shyr YM; Chiu JH; Wu CW; Lui WY; P'eng FK
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):121-31. PubMed ID: 8915115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.